A detailed history of Prostatis Group LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Prostatis Group LLC holds 62,570 shares of BDX stock, worth $15.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
62,570
Holding current value
$15.1 Million
% of portfolio
0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$238.39 - $265.32 $14.9 Million - $16.6 Million
62,570 New
62,570 $62.6 Million
Q4 2022

Mar 23, 2023

BUY
$218.29 - $256.91 $2.01 Million - $2.36 Million
9,193 Added 14.13%
74,259 $75 Million
Q3 2022

Mar 23, 2023

SELL
$51.03 - $264.23 $353,178 - $1.83 Million
-6,921 Reduced 9.61%
65,066 $65.1 Million
Q2 2022

Mar 23, 2023

BUY
$234.74 - $275.42 $1.79 Million - $2.1 Million
7,615 Added 11.83%
71,987 $72 Million
Q1 2022

Mar 23, 2023

BUY
$243.64 - $270.48 $856,150 - $950,466
3,514 Added 5.77%
64,372 $64.4 Million
Q4 2021

Mar 23, 2023

BUY
$230.08 - $250.94 $315,209 - $343,787
1,370 Added 2.3%
60,858 $60.9 Million
Q3 2021

Mar 23, 2023

BUY
$232.72 - $256.47 $148,009 - $163,114
636 Added 1.08%
59,488 $59.5 Million
Q2 2021

Mar 23, 2023

BUY
$232.65 - $254.58 $13.7 Million - $15 Million
58,852 New
58,852 $58.9 Million
Q4 2020

Mar 23, 2023

SELL
$221.92 - $245.94 $11.7 Million - $13 Million
-52,885 Closed
0 $0
Q3 2020

Mar 23, 2023

BUY
$215.77 - $276.76 $6.65 Million - $8.53 Million
30,804 Added 139.5%
52,885 $52.9 Million
Q2 2020

Mar 23, 2023

BUY
$219.9 - $263.41 $192,852 - $231,010
877 Added 4.14%
22,081 $22.1 Million
Q1 2020

Mar 23, 2023

SELL
$195.69 - $279.01 $762,212 - $1.09 Million
-3,895 Reduced 15.52%
21,204 $21.2 Million
Q4 2019

Mar 23, 2023

BUY
$236.45 - $266.82 $5.93 Million - $6.7 Million
25,099 New
25,099 $25.1 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $68.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Prostatis Group LLC Portfolio

Follow Prostatis Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.